A study on effectiveness of varma drug and varmam for lumbar spondylosis.

An open clinical trial to evaluate the therapeutic efficacy of Varma Kanji (Internal) and Lagu Vishamutti Thylam (External) with Varmam therapy in the management of Thandagavatham (Lumbar Spondylosis) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068474

Enrollment

Registered

2024-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Varma Kanji (Internal) Lagu vishamutti thylam (External) Varmam therapy: Internal - 60ml once a day for 48 DAYS External - 50ml Applied in low back region Varmam therapy - Once in a wee

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age : 18 - 60 years 2.Sex: Male, Female and Transgender 3.Score between 40 - 80 % in ABERDEEN LOW BACK PAIN SCALE 4.Patients willing to give radiological investigation and provide blood sample for lab investigation 5.Patient willing to sign Informed Consent

Exclusion criteria

Exclusion criteria: 1.Ankylosing spondylitis 2.K/C/o Trauma 3.Spondylolisthesis 4.Vertebral fracture 5.Tumour in Lumbar Vertebra 6.K/C/o TB 7.K/C/o Disc Prolapse

Design outcomes

Primary

Measure	Time frame
Mean reduction in pain, numbness & restriction of movements of Thandagavatham patients with trial medicinesTimepoint: 18 months	—

Secondary

Measure	Time frame
Aberdeen low back pain scale score reduced to 20%Timepoint: Screening - 6 months Patient enrollment - 6 Months Preparation of trial drug - 2 Months Data analysis - 1 month Follow up - 2 Months	—

Countries

India

Contacts

Public ContactDR D Periyasami

National Institute of Siddha

sami2011nis@gmail.com7358481734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026